Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Notch1 helps skin heal by attracting specific immune cells.

Key genes regulate hair follicle phase changes in Inner Mongolia cashmere goats.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Melatonin helps reduce aging signs in human eyelid skin.

Different γδ T cell types have unique roles in causing alopecia areata.

Hair follicles are crucial for maintaining skin barrier function.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

The treatment effectively reduces hair loss and improves hair growth with minimal side effects.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.